What does Follistatin-344 do? Benefits and evidence

Human gene-therapy findings do not establish a dose for follistatin-344 protein vials.

Also called: FS344, FST344, FS-344, Follistatin 344.

Myostatin pathway · Myostatin- and activin-binding protein precursor.

Follistatin binds signals that limit muscle growth. Human benefit studies delivered a follistatin gene, not protein from a vial. Small gene-therapy studies and an uncontrolled plasmid report cannot establish safe bodybuilding doses. Eleven men developed retinal fluid leakage after reported high-dose protein injections. Online products often contained the wrong material.

  • In a small gene-therapy study, four of six people with a muscle disease walked farther; this used a gene, not vial protein. (Studied in a trial)
  • Gene therapy versions are being studied for muscle loss with aging; no lifespan benefit has been shown. (Studied in a trial)
  • In an animal study, delivering the follistatin gene made thigh muscles larger. (animal)
  • People report muscle fullness, strength and growth, but none of it was checked in a controlled way. (Reported by users)

Uses in the sources

  • Gene delivery was studied in muscle disease. Myositis benefit is disputed; these findings cannot validate protein-vial use. (Studied in a trial) (source)
  • People inject products labeled follistatin-344 for muscle growth. No controlled human trial establishes benefit or a dose for those products. (Reported by users) (source)
  • Plasmid and AAV gene therapies are being studied for aging-related muscle decline. No lifespan benefit has been established. (Studied in a trial) (source)

Related to Follistatin-344

Sources

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.